Aspirin May Reduce Risk for CRC, But Only Among Certain Older Adults
Dec 19, 2023
New research suggests that initiating aspirin use in older patients is not associated with a lower risk of colorectal cancer in these individuals. Nevertheless, the pooled analysis of two cohort studies found that people who used aspirin before 70 years of age and continued into their 70s or later had a reduced risk of colorectal cancer. Reporting in a recent issue of JAMA Oncology, a multi-center team of investigators explained that aspirin is recommended for the prevention of colorectal cancer among adults between 50 and 59 years of age. Nevertheless, the recent ASPREE trial found conflicting results, and suggested a lack of benefit – and perhaps even possible harm – among older adults who take aspirin for this purpose.
Radiation Oncologists Met With Congressional Leaders to Reverse CMS Cuts and Provide Equal Access to Care
Radiation oncologists met with Congress to urge leaders to consider how the Medicare and Medicaid Services (CMS) proposal to make significant cuts to radiation oncology facilities could be detrimental to the survival of patients with Read more…
FDA Approves Neoadjuvant Pembrolizumab Combination for Early TNBC Indication
The FDA granted approval to the supplemental biologics license application (sBLA) for pembrolizumab (Keytruda) as neoadjuvant therapy for patients with high-risk early-stage triple-negative breast cancer (TNBC) when given in combination with chemotherapy followed by single-agent Read more…
Recommended TVUS Screening Thresholds May Miss Endometrial Cancer in Black Women
Adherence to current clinical guidelines for the evaluation of postmenopausal bleeding may result in systematic underdiagnosis of endometrial cancer (EC) in Black women, according to a study published online July 15 in JAMA Oncology. Kemi M. Read more…